ベンリスタの世界市場レポート2025年：疫学、パイプライン分析、市場インサイトと予測

ベンリスタの市場規模は今後数年で急成長が見込まれます。2029年にはCAGR11％で36億7,220万米ドルに成長します。予測期間における成長の背景には、精密医療に対する需要の高まり、希少疾患に対する意識の高まり、生物学的単剤療法の利用拡大、免疫学への投資の増加、政府支援の高まりなどがあります。予測期間における主要動向としては、免疫学の進歩、革新的なドラッグデリバリーシステム、研究機関との連携、戦略的パートナーシップ、医薬品開発におけるAIや機械学習などが挙げられます。

自己免疫疾患の罹患率の増加は、今後のベンリスタ市場の成長を促進すると予測されます。自己免疫疾患は、免疫系が誤って健康な細胞、組織、臓器を攻撃する疾患です。これらの疾患の有病率の上昇は、診断方法の改善、環境的誘因、ライフスタイルの変化、遺伝的要因、高齢化などの要因によるものです。ベンリスタは、過剰な免疫反応に関与するBリンパ球刺激因子（BLyS）タンパク質を標的とすることにより、自己免疫疾患、特に全身性エリテマトーデス（SLE）の管理に役立ちます。これにより、有害なB細胞の生存率を低下させ、健康な組織を攻撃するのを防ぎ、疾患活動性をコントロールすることができます。例えば、国民健康会議は2024年3月に、自己免疫疾患は米国で約5,000万人に影響を及ぼしていると報告しているが、診断上の課題から本当の数はもっと多い可能性があります。自己免疫疾患は増加しており、年間3％から12％の増加を示唆する研究もあります。さらに、国立医療図書館によると、自己免疫疾患の世界的発生率は毎年19.1％増加し、有病率は毎年12.5％増加しています。したがって、自己免疫疾患患者の増加がベンリスタの需要を促進しています。

また、ヘルスケア支出の増加もベンリスタ市場の拡大に寄与すると予想されています。ヘルスケア支出は、病院治療、医薬品、医療管理などの医療サービスに対するすべての支出をカバーしています。高齢化、慢性疾患の負担増、医療技術の進歩などにより、医療費は増加傾向にあります。加えて、インフレと医療需要の増加がコストを押し上げています。その結果、医療支出の増加は、狼瘡のような慢性自己免疫疾患の治療への投資を増加させ、生物製剤の需要増につながることで、ベンリスタ市場を支えています。例えば、国家統計局は2024年5月に、英国のヘルスケア支出は2022年の0.9%増に対し、2022～2023年にかけて5.6%増となったと報告しています。2023年、英国のヘルスケア支出は約3,176億3,000万米ドル（2,920億英ポンド）に達しました。このように、ヘルスケア支出の伸びがベンリスタ市場を押し上げています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 バイオ医薬品市場における製品特性

• 分子タイプ
• 投与経路（ROA）
• 作用機序（MOA）
• 安全性と有効性

第4章 市場動向と戦略

第5章 市場：金利、インフレ、地政学的要因、新型コロナとその回復が市場に与える影響を含むマクロ経済シナリオ

第6章 世界の成長分析と戦略分析フレームワーク

• 世界のベンリスタ：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のベンリスタ市場：成長率分析
• 世界のベンリスタ市場の実績：規模と成長、2019～2024年
• 世界のベンリスタ市場の予測：規模と成長、2024～2029年、2034年
• 世界のベンリスタ：総潜在市場規模（TAM）

第7章 世界の価格分析と予測

第8章 市場セグメンテーション

• 世界のベンリスタ市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 静脈内（IV）
• 皮下（SC）
• 世界のベンリスタ市場：疾患別、実績と予測、2019～2024年、2024～2029年、2034年
• 全身性エリテマトーデス（SLE）
• ループス腎炎（LN）
• その他の関連症状
• 世界のベンリスタ市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• クリニック
• 在宅ケア
• 専門薬局

第9章 臨床適応症の世界的疫学

• 薬剤の副作用
• 臨床適応症の発症率と有病率

第10章 地域別・国別分析

• 世界のベンリスタ市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のベンリスタ市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第11章 アジア太平洋市場

第12章 中国市場

第13章 インド市場

第14章 日本市場

第15章 オーストラリア市場

第16章 韓国市場

第17章 西欧市場

第18章 英国市場

第19章 ドイツ市場

第20章 フランス市場

第21章 東欧市場

第22章 北米市場

第23章 米国市場

第24章 カナダ市場

第25章 南米市場

第26章 中東市場

第27章 アフリカ市場

第28章 競合情勢と企業プロファイル

• ベンリスタ市場：競合情勢
• ベンリスタ市場：企業プロファイル
  • GlaxoSmithKline plc

第29章 世界市場：パイプライン分析

第30章 世界の市場競合ベンチマーキングとダッシュボード

第31章 主要な合併と買収

第32章 最近の市場動向

第33章 市場の潜在力が高い国、戦略

• ベンリスタ市場、2029年：新たな機会を提供する国
• ベンリスタ市場、2029年：新たな機会を提供するセグメント
• ベンリスタ市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第34章 付録

Benlysta is a biologic medication known as belimumab, primarily used for the treatment of systemic lupus erythematosus (SLE), an autoimmune disease. It works by targeting and inhibiting the BLyS protein, which reduces the survival of B cells, helping to decrease disease activity and prevent organ damage. Benlysta is administered through intravenous infusion or subcutaneous injection.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main methods of benlysta administration are intravenous (IV) and subcutaneous (SC). IV administration involves delivering the medication directly into a vein, ensuring rapid absorption into the bloodstream. The clinical indications for Benlysta include systemic lupus erythematosus (SLE), lupus nephritis (LN), and other conditions. Benlysta is used by various end users, including hospitals, clinics, home care settings, and specialty pharmacies, ensuring broad accessibility and flexibility in treatment.

The benlysta market research report is one of a series of new reports from The Business Research Company that provides benlysta market statistics, including benlysta industry global market size, regional shares, competitors with a benlysta market share, detailed benlysta market segments, market trends and opportunities, and any further data you may need to thrive in the benlysta industry. This benlysta market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The benlysta market size is expected to see rapid growth in the next few years. It will grow to $3,672.2 million in 2029 at a compound annual growth rate (CAGR) of 11%. The growth in the forecast period can be attributed to growing demand for precision medicine, growth in rare disease awareness, growing use of biologic monotherapies, rising investments in immunology, and rising government support. Major trends in the forecast period include advances in immunology, innovative drug delivery systems, collaboration with research institutions, strategic partnerships, and AI and machine learning in drug development.

The growing incidence of autoimmune diseases is anticipated to drive the growth of the benlysta market in the future. Autoimmune diseases are conditions where the immune system mistakenly attacks healthy cells, tissues, and organs. The rising prevalence of these diseases is attributed to factors such as better diagnostic methods, environmental triggers, lifestyle changes, genetic factors, and an aging population. Benlysta helps manage autoimmune diseases, particularly systemic lupus erythematosus (SLE), by targeting the B-lymphocyte stimulator (BLyS) protein, which is involved in the overactive immune response. This helps reduce the survival of harmful B cells, preventing them from attacking healthy tissues and controlling disease activity. For example, the National Health Council reported in March 2024 that autoimmune diseases affect around 50 million people in the United States, though the true number may be higher due to diagnostic challenges. Autoimmunity is increasing, with some studies suggesting an annual rise of 3% to 12%. Additionally, according to the National Library of Medicine, the global incidence of autoimmune diseases increases by 19.1% annually, with prevalence rising by 12.5% each year. Therefore, the increase in autoimmune disease cases is fueling the demand for benlysta.

The growth in healthcare spending is also expected to contribute to the expansion of the benlysta market. Healthcare expenditure covers all spending on medical services, including hospital care, pharmaceuticals, and healthcare administration. It is rising due to an aging population, the growing burden of chronic diseases, and advancements in medical technology. In addition, inflation and increasing healthcare demands are driving up costs. As a result, rising healthcare spending supports the benlysta market by increasing investments in treatments for chronic autoimmune diseases such as lupus, leading to higher demand for biologic therapies. For example, the Office for National Statistics reported in May 2024 that healthcare spending in the UK grew by 5.6% between 2022 and 2023, compared to a 0.9% increase in 2022. In 2023, UK healthcare expenditure reached approximately $317.63 billion (£292 billion). Thus, the growth in healthcare spending is boosting the benlysta market.

A significant trend in the benlysta market is the development of innovative products, such as autoinjectors, which improve treatment accessibility and convenience, especially for pediatric SLE patients. Autoinjectors are devices that allow patients to quickly and easily administer medication, often for chronic conditions or emergencies. In May 2024, GlaxoSmithKline announced that the FDA approved the Benlysta (belimumab) autoinjector for pediatric patients aged 5 years and older with SLE. This approval provides the first at-home treatment option for children who need belimumab, enabling subcutaneous administration and eliminating the need for regular clinical visits. The autoinjector enhances convenience and flexibility for caregivers, addressing the significant impact lupus has on children, including higher rates of organ damage.

The key company operating in the benlysta market is GlaxoSmithKline plc

North America was the largest region in the benlysta market in 2024. The regions covered in benlysta report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the benlysta market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The benlysta market consists of sales of products such as immune system modulators, infusion equipment and biologic drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Benlysta Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on benlysta market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for benlysta ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The benlysta market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Route Of Administration: Intravenous (IV); Subcutaneous (SC)
• 2) By Clinical Indication: Systemic Lupus Erythematosus (SLE); Lupus Nephritis (LN); Other Related Conditions
• 3) By End Users: Hospitals; Clinics; Home Care Settings; Specialty Pharmacies
• Companies Mentioned: GlaxoSmithKline plc
• Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Benlysta Market Characteristics

3. Benlysta Market Biologic Drug Characteristics

• 3.1. Molecule Type
• 3.2. Route Of Administration (ROA)
• 3.3. Mechanism Of Action (MOA)
• 3.4. Safety And Efficacy

4. Benlysta Market Trends And Strategies

5. Benlysta Market -Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Benlysta Growth Analysis And Strategic Analysis Framework

• 6.1. Global Benlysta PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 6.2. Analysis Of End Use Industries
• 6.3. Global Benlysta Market Growth Rate Analysis
• 6.4. Global Benlysta Historic Market Size and Growth, 2019 - 2024, Value ($ Million)
• 6.5. Global Benlysta Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)
• 6.6. Global Benlysta Total Addressable Market (TAM)

7. Global Benlysta Pricing Analysis & Forecasts

8. Benlysta Market Segmentation

• 8.1. Global Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• Intravenous (IV)
• Subcutaneous (SC)
• 8.2. Global Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• Systemic Lupus Erythematosus (SLE)
• Lupus Nephritis (LN)
• Other Related Conditions
• 8.3. Global Benlysta Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• Hospitals
• Clinics
• Home Care Settings
• Specialty Pharmacies

9. Global Benlysta Epidemiology Of Clinical Indications

• 9.1. Drug Side Effects
• 9.2. Incidence And Prevalence of Clinical Indications

10. Benlysta Market Regional And Country Analysis

• 10.1. Global Benlysta Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 10.2. Global Benlysta Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Benlysta Market

• 11.1. Asia-Pacific Benlysta Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 11.3. Asia-Pacific Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 11.4. Asia-Pacific Benlysta Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Benlysta Market

• 12.1. China Benlysta Market Overview
• 12.2. China Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
• 12.3. China Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
• 12.4. China Benlysta Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Benlysta Market

• 13.1. India Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 13.2. India Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 13.3. India Benlysta Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Benlysta Market

• 14.1. Japan Benlysta Market Overview
• 14.2. Japan Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 14.3. Japan Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 14.4. Japan Benlysta Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Benlysta Market

• 15.1. Australia Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 15.2. Australia Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 15.3. Australia Benlysta Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Benlysta Market

• 16.1. South Korea Benlysta Market Overview
• 16.2. South Korea Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 16.3. South Korea Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 16.4. South Korea Benlysta Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Benlysta Market

• 17.1. Western Europe Benlysta Market Overview
• 17.2. Western Europe Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 17.3. Western Europe Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 17.4. Western Europe Benlysta Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Benlysta Market

• 18.1. UK Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 18.2. UK Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 18.3. UK Benlysta Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Benlysta Market

• 19.1. Germany Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 19.2. Germany Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 19.3. Germany Benlysta Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Benlysta Market

• 20.1. France Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 20.2. France Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 20.3. France Benlysta Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Benlysta Market

• 21.1. Eastern Europe Benlysta Market Overview
• 21.2. Eastern Europe Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 21.3. Eastern Europe Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 21.4. Eastern Europe Benlysta Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Benlysta Market

• 22.1. North America Benlysta Market Overview
• 22.2. North America Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 22.3. North America Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 22.4. North America Benlysta Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Benlysta Market

• 23.1. USA Benlysta Market Overview
• 23.2. USA Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 23.3. USA Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 23.4. USA Benlysta Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Benlysta Market

• 24.1. Canada Benlysta Market Overview
• 24.2. Canada Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 24.3. Canada Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 24.4. Canada Benlysta Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Benlysta Market

• 25.1. South America Benlysta Market Overview
• 25.2. South America Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 25.3. South America Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 25.4. South America Benlysta Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Benlysta Market

• 26.1. Middle East Benlysta Market Overview
• 26.2. Middle East Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 26.3. Middle East Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 26.4. Middle East Benlysta Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Benlysta Market

• 27.1. Africa Benlysta Market Overview
• 27.2. Africa Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 27.3. Africa Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 27.4. Africa Benlysta Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Benlysta Market Competitive Landscape And Company Profiles

• 28.1. Benlysta Market Competitive Landscape
• 28.2. Benlysta Market Company Profiles
  • 28.2.1. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

29. Global Benlysta Market Pipeline Analysis

• 29.1. High Level Clinic Trail Information

30. Global Benlysta Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Benlysta Market

32. Recent Developments In The Benlysta Market

33. Benlysta Market High Potential Countries, Segments and Strategies

• 33.1 Benlysta Market In 2029 - Countries Offering Most New Opportunities
• 33.2 Benlysta Market In 2029 - Segments Offering Most New Opportunities
• 33.3 Benlysta Market In 2029 - Growth Strategies
  • 33.3.1 Market Trend Based Strategies
  • 33.3.2 Competitor Strategies

34. Appendix

• 34.1. Abbreviations
• 34.2. Currencies
• 34.3. Historic And Forecast Inflation Rates
• 34.4. Research Inquiries
• 34.5. The Business Research Company
• 34.6. Copyright And Disclaimer